Inito Secures $29M to Expand At-Home Diagnostics with AI

Inito, an at-home diagnostics startup, raised $29M in Series B funding led by Bertelsmann India Investments. The funding will support expansion beyond fertility testing into broader hormone and health diagnostics utilizing AI-enabled antibody engineering. Inito aims to build a stable foundation for at-home diagnostics that historically required clinical infrastructure, targeting wider health monitoring.